Clinical Trials
4 trialsNCT02069340 2017-04-11
Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid
University of Southern California
Phase NA Withdrawn
NCT01062503 2015-04-27
SubDueP
University Health Network, Toronto
Completed
NCT01404702 2014-12-02
Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
University of Alabama at Birmingham
Phase 1 Terminated
NCT00126386 2011-11-21
Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community
AHS Cancer Control Alberta
Phase NA Completed